Papa Medical ^{Filed, US Offering, Nasdaq: PAPA}

We are the first end-to-end innovative cannabis dosing solution provider in the US that possesses the medical atomization or nebulizing background and sells nebulizer, according to the Frost & Sullivan Report. We deeply engage in the key activities in the cannabis and consuming E-vapors industry, from the research and development, formulation design, e-liquid production, e-liquid filling to e-liquid co-packing services. We believe our full-cycle operations and leading market position will position us to further capitalize on the growth potential of US’ cannabis E-vapors market. Leveraging our in-house innovative technology and strong manufacturing capabilities and in-depth insights into end-users’ needs to develop superior e-vapor products, we provide comprehensive innovative cannabis dosing solutions to companies in the cannabis and tobacco industries. Deeply involving in key activities including the formulation designing, the manufacturing and the final brand operating process at the same time, we are able to optimize production process based on designing, or can adjust the designing and manufacturing according to the market’s requirements in a timely manner.